Thomas Balland

Director/Board Member at

SymbioFCell SA

48 year

61 connections

Health Technology

Technology Services

Consumer Services

Profile

Thomas Balland is currently a Director at AGC Biologics A, Director at CMC Luxembourg Holding SARL, Director at SymbioFCell SA, Director at Gamma SA, and Member-Supervisory Board at cooee GmbH.
He has previously worked as a Director at SpineVision SA, Independent Director at Kiora Pharmaceuticals, Director-Investments at PC Associés SAS, Director at HERE Deutschland GmbH, Director at Monte Cristo Multimédia SA, Director at InGen Biosciences SA, Director at Immutep SAS, Director at NavX SASU, Director at SpineGuard SA, and Director at Technolas Perfect Vision GmbH.
He has also served as a Member-Supervisory Board at Traqueur SA, 20, and Aupeo GmbH.
Mr. Balland has an undergraduate degree from ESCP Europe Campus Paris and an undergraduate degree from Institut National des Sciences Appliquées de Lyon.

Thomas Balland active positions

Companies	Position	Start
SymbioFCell SA SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems	Director/Board Member	2011-06-26
cooee GmbH cooee GmbH Commercial Printing/FormsCommercial Services Operates an online 3D Internet communication platform	Director/Board Member	2011-06-26
CMC Luxembourg Holding SARL	Director/Board Member	-
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals	Director/Board Member	2003-12-31
Gamma SA Gamma SA Medical SpecialtiesHealth Technology Specialized in immunological techniques for in vitro medical diagnostic use	Director/Board Member	-

All active positions of Thomas Balland

Former positions of Thomas Balland

Companies	Position	End
SPINEGUARD	Director/Board Member	2017-09-30
PC Associés SAS PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology.	Chief Investment Officer	2015-12-09
TECHNOLAS Perfect Vision GmbH TECHNOLAS Perfect Vision GmbH Medical SpecialtiesHealth Technology Develops and markets laser and surgical technology solutions	Director/Board Member	-
HERE Deutschland GmbH HERE Deutschland GmbH Packaged SoftwareTechnology Services Develops and supplies software	Director/Board Member	-
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Thomas Balland's experience

Training of Thomas Balland

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Balland's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
SpineVision SAS SpineVision SAS Medical SpecialtiesHealth Technology Develops and markets implants for the treatment of spinal disorders	Health Technology
Kiora Pharmaceuticals, Inc. Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases	Health Technology
Traqueur SA Traqueur SA Electronics/AppliancesConsumer Durables Manufactures tracking devices for automotive industry	Consumer Durables
PC Associés SAS PC Associés SAS Investment ManagersFinance IPSA is an active manager focused on science-based companies within the European Union. They invest internationally in the ICT, life sciences, natural resources and energy sectors, particularly in France, the UK, Germany, the Netherlands and Denmark. They target high-growth businesses with innovative technology and an experienced management team with a proven track record of growth. They seek board representation, actively participate in strategic decisions, and aim to build their portfolio companies into market leaders. The firm prefers to be the lead or co-lead investor and invests between EUR 1-5 million per round, participating in successive financing rounds. They invest across development stages from startups to pre-IPO companies, and accompany their portfolio companies throughout their development. They favor companies with disruptive products or technology which have reached an advanced stage of development, are likely to generate significant revenues within two to three years, and have exit visibility through IPO or trade sale. In the life sciences sector, IPSA focuses on clinical-stage drug development, medical devices, drug delivery and development services. Their ICT investments are in domains including content, software, enabling technology and infrastructure. The firm also invests in the energy and natural resources sector, focusing on exploration and production, as well as on renewable energy and clean technology.	Finance
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals	Health Technology
HERE Deutschland GmbH HERE Deutschland GmbH Packaged SoftwareTechnology Services Develops and supplies software	Technology Services
ESCP Europe Campus Paris ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Institut National des Sciences Appliquées de Lyon Institut National des Sciences Appliquées de Lyon Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Monte Cristo Multimédia SA Monte Cristo Multimédia SA Packaged SoftwareTechnology Services Develops and produces PC and console video games	Technology Services
20/10 Perfect Vision AG 20/10 Perfect Vision AG Medical SpecialtiesHealth Technology Develops, manufactures and markets technologies for eye surgeries	Health Technology
cooee GmbH cooee GmbH Commercial Printing/FormsCommercial Services Operates an online 3D Internet communication platform	Commercial Services
InGen Biosciences SA InGen Biosciences SA Medical SpecialtiesHealth Technology Develops in-vitro diagnostic products	Health Technology
Immutep SAS Immutep SAS Pharmaceuticals: MajorHealth Technology Develops T-cell response-based immuno therapeutics for the treatment of cancer and infectious diseases	Health Technology
NavX SASU NavX SASU Packaged SoftwareTechnology Services Develops and markets mobile software applications	Technology Services
Aupeo GmbH Aupeo GmbH Miscellaneous Commercial ServicesCommercial Services Provides personalized audio streams for Internet-capable hardware devices	Commercial Services
SpineGuard SA SpineGuard SA Medical SpecialtiesHealth Technology Designs and manufactures medical devices	Health Technology
TECHNOLAS Perfect Vision GmbH TECHNOLAS Perfect Vision GmbH Medical SpecialtiesHealth Technology Develops and markets laser and surgical technology solutions	Health Technology
CMC Luxembourg Holding SARL
SymbioFCell SA SymbioFCell SA Electrical ProductsProducer Manufacturing Manufactures hydrogen fuel systems	Producer Manufacturing
Gamma SA Gamma SA Medical SpecialtiesHealth Technology Specialized in immunological techniques for in vitro medical diagnostic use	Health Technology